127 related articles for article (PubMed ID: 1661347)
1. Proto-oncogene expression in three human hepatoma cell lines, HCC-M, HCC-T and PLC/PRF/5.
Saito H; Morizane T; Watanabe T; Kagawa T; Miyaguchi S; Kumagai N; Tsuchimoto K; Tsuchiya M
Keio J Med; 1991 Sep; 40(3):139-45. PubMed ID: 1661347
[TBL] [Abstract][Full Text] [Related]
2. Expression of oncogenes in human hepatoma cell lines.
Ting LP; Jeng KS; Chou CK; Su TS; Hu CP; Wong FH; Chang HK; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):141-50. PubMed ID: 2854043
[TBL] [Abstract][Full Text] [Related]
3. Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M and HCC-T.
Saito H; Morizane T; Watanabe T; Kagawa T; Miyaguchi S; Kumagai N; Tsuchiya M
Int J Cancer; 1991 May; 48(2):291-6. PubMed ID: 1708367
[TBL] [Abstract][Full Text] [Related]
4. Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines.
Farshid M; Tabor E
J Med Virol; 1992 Dec; 38(4):235-9. PubMed ID: 1335479
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines.
Tada S; Saito H; Tsunematsu S; Ebinuma H; Wakabayashi K; Masuda T; Ishii H
Int J Oncol; 1998 Dec; 13(6):1207-16. PubMed ID: 9824633
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
[TBL] [Abstract][Full Text] [Related]
8. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma.
Tsuda H; Hirohashi S; Shimosato Y; Ino Y; Yoshida T; Terada M
Jpn J Cancer Res; 1989 Mar; 80(3):196-9. PubMed ID: 2542205
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of cellular oncogenes during rat liver development.
Zhang XK; Wang Z; Lee A; Huang DP; Chiu JF
Cancer Lett; 1988 Aug; 41(2):147-55. PubMed ID: 2456853
[TBL] [Abstract][Full Text] [Related]
10. Oncogene expression in human hepatoma cells PLC/PRF/5.
Motoo Y; Mahmoudi M; Osther K; Bollon AP
Biochem Biophys Res Commun; 1986 Feb; 135(1):262-8. PubMed ID: 3006683
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the expression of Bin1, a putative suppressor, in human hepatoma cells.
Livezey KW; Negorev D; Simon D
Cancer Genet Cytogenet; 2000 Jan; 116(1):35-9. PubMed ID: 10616529
[TBL] [Abstract][Full Text] [Related]
12. The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma.
Yang DH; Huang W; Cui J; Shu JC; Tang SH; Zhang WJ; Liang JH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):86-9. PubMed ID: 14969845
[TBL] [Abstract][Full Text] [Related]
13. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
Richards CA; Short SA; Thorgeirsson SS; Huber BE
Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling.
Bose S; Sakhuja P; Bezawada L; Agarwal AK; Kazim SN; Khan LA; Sarin SK; Ramakrishna G
J Gastroenterol Hepatol; 2011 Jan; 26(1):135-44. PubMed ID: 21175807
[TBL] [Abstract][Full Text] [Related]
16. The expression of oncogenes in human developing liver and hepatomas.
Zhang XK; Huang DP; Chiu DK; Chiu JF
Biochem Biophys Res Commun; 1987 Feb; 142(3):932-8. PubMed ID: 3030308
[TBL] [Abstract][Full Text] [Related]
17. Cellular oncogenes in human teratocarcinoma cell lines.
Tesch H; Fürbass R; Casper J; Lyons J; Bartram CR; Schmoll HJ; Bronson DL
Int J Androl; 1990 Oct; 13(5):377-88. PubMed ID: 2283183
[TBL] [Abstract][Full Text] [Related]
18. A lack of direct role of hepatitis B virus in the activation of ras and c-myc oncogenes in human hepatocellular carcinogenesis.
Lee HS; Rajagopalan MS; Vyas GN
Hepatology; 1988; 8(5):1116-20. PubMed ID: 2843452
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line.
Huber BE; Dearfield KL; Williams JR; Heilman CA; Thorgeirsson SS
Cancer Res; 1985 Sep; 45(9):4322-9. PubMed ID: 2992777
[TBL] [Abstract][Full Text] [Related]
20. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]